December 4: Virtual
December 9 - 10: Royal Sonesta Harbor Court, Baltimore, MD
This State of the Science Conference on OAB and Cognitive Impairment brings together thought leaders representing private and public stakeholders who are actively engaged in overactive bladder (OAB) treatment and research. The conference will seek to understand the role of conservative treatment modalities including behavioral and pharmacologic therapies in older woman; review the evidence regarding long-term use of anticholinergic medications and risk of the development of cognitive impairment, dementia, and Alzheimer’s disease; review and discuss the current algorithm for the treatment of OAB in the setting of medication risks for older (>65 years) and younger women; and understand the evidence regarding use of third-line therapies in women at risk for cognitive impairment.
Attendees will have an opportunity to hear current the current state of the science from both a research and clinical perspective through lecture and panel discussions and will have the ability to participate in work group discussions related to the current treatment algorithm, identification of research gaps and research needs, quality outcome measures, OAB treatment initiatives and impact on insurance provider coverage guidelines.
The desired outcome of this conference is to produce an evidence-based, multi-dimensional, comprehensive strategy that will become an AUGS driven action plan to advance OAB research and treatment initiatives.